Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
TWi Pharmaceuticals moves its U.S. office from California to New Jersey. New U.S. Executive Vice President
November 13, 2015 Off

TWi Pharmaceuticals moves its U.S. office from California to New Jersey. New U.S. Executive Vice President

By Dino Mustafić

TWi Pharmaceuticals has appointed Rick Pallokat as the Executive Vice President of its U.S. subsidiary, to be responsible for its US Operations as it…

Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way
November 13, 2015 Off

Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way

By Dino Mustafić

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, reported net revenue $5.6 million for the third quarter 2015.

Vishnu Chemicals reappointed Krishna Murthy, Chairman & Managing Director
November 13, 2015 Off

Vishnu Chemicals reappointed Krishna Murthy, Chairman & Managing Director

By Dino Mustafić

Vishnu Chemicals has reappointed of Ch. Krishna Murthy, Chairman & Managing Director for a period of 5 years

Roche exits four manufacturing sites, job cuts imminent
November 12, 2015 Off

Roche exits four manufacturing sites, job cuts imminent

By Dino Mustafić

Swiss-based Roche plans to exit four manufacturing sites globally. Workforce reduction is imminent.

Akers Biosciences in managerial changes
November 12, 2015 Off

Akers Biosciences in managerial changes

By Dino Mustafić

Akers Biosciences has appointed Raza Bokhari M.D. as a Non-executive Director of the company.

Silence Therapeutics welcomes new board member
November 12, 2015 Off

Silence Therapeutics welcomes new board member

By Dino Mustafić

Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…

Study shows IONA test can predict the presence of Down’s, Edward’s, and Patau’s syndrome
November 12, 2015 Off

Study shows IONA test can predict the presence of Down’s, Edward’s, and Patau’s syndrome

By Dino Mustafić

Study demonstrates the IONA test can accurately predict the presence of the trisomies 21, 18, and 13. Being user-friendly, cost effective and CE-marked will overcome some of the limitations of existing commercial technologies to facilitate implementation in local laboratories.

Horizon Pharma about Express Scripts’ business practices
November 11, 2015 Off

Horizon Pharma about Express Scripts’ business practices

By Dino Mustafić

Horizon Pharma about Express Scripts’ business practices: “Express Scripts… also operates its own mail-order pharmacy and thus is a direct competitor of small, independent specialty pharmacies”

Horizon Pharma and ALR will together study RAYOS
November 11, 2015 Off

Horizon Pharma and ALR will together study RAYOS

By Dino Mustafić

Horizon Pharma on Wednesday announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE).

Anavex confirms positive efficacy Phase2 Alzheimer’s trial for its Anavex 2-73 datahad
November 11, 2015 Off

Anavex confirms positive efficacy Phase2 Alzheimer’s trial for its Anavex 2-73 datahad

By Dino Mustafić

Anavex has confirmed the information about positive safety and cognitive efficacy data from the Phase 2a Alzheimer’s trial for ANAVEX 2-73.

Posts pagination

Previous 1 … 6,274 6,275 6,276 … 6,294 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Biocodex Introduces Fullify™, a First-of-Its-Kind Precision Probiotic Clinically Shown to Activate the Gut-Brain Pathway to Support Appetite Management

January 29, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine